TY - JOUR
T1 - Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia
AU - Castro, Aura Lucia Leal
AU - Camacho-Moreno, Germán
AU - Montañez-Ayala, Anita
AU - Varón-Vega, Fabio
AU - Alvarez-Rodríguez, José Camilo
AU - Valderrama-Beltrán, Sandra
AU - Ariza, Beatriz Elena
AU - Pancha, Oscar
AU - Santana, Ana Yadira
AU - Flórez, Nella Sánchez
AU - Reyes, Patricia
AU - Ruiz, Jaime
AU - Beltran, Claudia
AU - Prieto, Emilia
AU - Rojas, Monica
AU - Urrego-Reyes, Juan
AU - Parellada, Cintia Irene
N1 - Publisher Copyright:
© 2022 Merck Sharp & Dohme Corp., a subsidiary Merck & Co., Inc., The Author(s).
PY - 2022/6
Y1 - 2022/6
N2 - Background: There is scarce information on the burden of invasive pneumococcal disease (IPD) among adults in low- and middle-income countries. This study aimed to describe the clinical outcomes and microbiological characteristics associated with IPD in adults and subgroups aged 18-59 years and ≥60 years in Colombia Methods: A retrospective chart review study was conducted in five institutions of Bogotá from January 2011 to December 2017. Analyses were carried out for overall population and stratified by age group (18-59; ≥ 60 years) Results: There were 169 IPD cases; median age was 58 years, 51.5% were male, and 80.5% had at least one comorbidity. Bacteremic pneumonia was the most common presentation (63.9%). The median length of hospital stay was 12 days with high healthcare resource utilization (HCRU): 58.6% required ICU and 53.3% inotropic support. Overall case-fatality rate (CFR) was 41.4%. Clinical outcomes were worse in patients ≥60 years old with significantly higher CFR and HCRU (ICU admission, mechanical ventilation, and inotropic support) compared to those aged 18-59 years. The most frequent serotypes were 3, 6 A/C, 14, and 19A. The sensitivity to penicillin in meningitis and non-meningitis isolates were 75% and 89.1% respectively Conclusions: IPD was associated with a substantial burden in adults and worse clinical outcomes and HCRU in older adults in Colombia. Surveillance data combined with clinical outcomes have the potential to inform age-based pneumococcal vaccination policies.
AB - Background: There is scarce information on the burden of invasive pneumococcal disease (IPD) among adults in low- and middle-income countries. This study aimed to describe the clinical outcomes and microbiological characteristics associated with IPD in adults and subgroups aged 18-59 years and ≥60 years in Colombia Methods: A retrospective chart review study was conducted in five institutions of Bogotá from January 2011 to December 2017. Analyses were carried out for overall population and stratified by age group (18-59; ≥ 60 years) Results: There were 169 IPD cases; median age was 58 years, 51.5% were male, and 80.5% had at least one comorbidity. Bacteremic pneumonia was the most common presentation (63.9%). The median length of hospital stay was 12 days with high healthcare resource utilization (HCRU): 58.6% required ICU and 53.3% inotropic support. Overall case-fatality rate (CFR) was 41.4%. Clinical outcomes were worse in patients ≥60 years old with significantly higher CFR and HCRU (ICU admission, mechanical ventilation, and inotropic support) compared to those aged 18-59 years. The most frequent serotypes were 3, 6 A/C, 14, and 19A. The sensitivity to penicillin in meningitis and non-meningitis isolates were 75% and 89.1% respectively Conclusions: IPD was associated with a substantial burden in adults and worse clinical outcomes and HCRU in older adults in Colombia. Surveillance data combined with clinical outcomes have the potential to inform age-based pneumococcal vaccination policies.
KW - Streptococcus pneumoniae, pneumococcal infection, adult, older adult, mortality
KW - healthcare resource utilization, antimicrobial resistance
KW - antimicrobial resistance
KW - pneumococcal infection
KW - adult
KW - older adult
KW - mortality healthcare
KW - resource utilization
UR - https://www.scopus.com/pages/publications/85150876874
U2 - 10.1016/j.ijregi.2022.04.007
DO - 10.1016/j.ijregi.2022.04.007
M3 - Article
AN - SCOPUS:85150876874
SN - 2772-7076
VL - 3
SP - 293
EP - 299
JO - IJID Regions
JF - IJID Regions
ER -